Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
Concurrent BCR::ABL1 and SET::NUP214 fusions in blast-phase chronic myeloid leukemia.
Journal: Cancer genetics
Published: July 20, 2026
Transfusion Support After CAR-T Cell Therapy: Real-World Patterns Across Commercial Products and Disease Groups.
Journal: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
Published: June 01, 2026
False-positive HIV-1 RNA detection following obecabtagene autoleucel.
Journal: Bone marrow transplantation
Published: April 15, 2026
Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis.
Journal: Transplantation and cellular therapy
Published: April 03, 2026
Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Journal: American journal of hematology
Published: March 09, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival.
Journal: Transplantation and cellular therapy
Published: February 12, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: January 14, 2026
Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2.
Journal: Journal of hematology & oncology
Published: December 30, 2025
Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era.
Journal: Mycopathologia
Published: October 27, 2025
Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research Analysis.
Journal: Transplantation and cellular therapy
Published: August 22, 2025
Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: July 18, 2025
Last Updated: 09/26/2026